CANbridge Pharmaceuticals Inc 2022 Sustainability Report
Company: CANbridge Pharmaceuticals Inc
Sector: Manufacturing
Country: China
Year: 2022
Type: Sustainability Report
Pages: 36
The report describes CANbridge’s Board-led ESG oversight and a four-step materiality assessment for its 2022 operations. It reports 2022 Scope 1, Scope 2, and Scope 3 emissions, with Scope 2 increasing alongside electricity use. The company had 127 employees, trained 129 employees for 2,325.5 total hours, and reported no work-related fatalities. Community investment included approximately HKD6,336,000 in donations and 134 hours of employee service.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.